Skip to Main Content

Author Details

Ian Frank
IF School of Medicine, University of Pennsylvania
1987
196
60
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36935288Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.Vaccine2023
37795976Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.J Infect Dis2023
37609144Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection.bioRxiv2023
37300931Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.EBioMedicine2023
36877848HIV post-treatment controllers have distinct immunological and virological features.Proc Natl Acad Sci U S A2023
35192740A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019.J Int AIDS Soc2022
35536669A phase I trial of cyclosporine for hospitalized patients with COVID-19.JCI Insight2022
35687192Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).AIDS Behav2022
35848549Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy.AIDS2022
36136590Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19.JCI Insight2022
36380851Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trials.JAMIA Open2022
36351430Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy.Cell Rep Med2022
36261003SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations.Cell Rep2022
35145311Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.Nat Med2022
32860114Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials.AIDS Behav2021
33907765Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity.medRxiv2021
33730454Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.N Engl J Med2021
33587505Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.J Acquir Immune Defic Syndr2021
33887209Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.Lancet Infect Dis2021
33831911Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.AIDS2021
34871308Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.PLoS Med2021
34648302mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.Science2021
34379922Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.N Engl J Med2021
34551263Effects of a Health Promotion Intervention on Physical Activity in African American Men Living with HIV: Randomized Controlled Trial.AIDS Patient Care STDS2021
34788233A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.J Clin Invest2021
34462751mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern.bioRxiv2021
34459907Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals.JAMA Netw Open2021
34237028Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration.JCI Insight2021
34086344Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH.Eur J Immunol2021
34166231Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.J Clin Invest2021
33972943Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.bioRxiv2021
34081073Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.JAMA2021
33400589Prior Sexually Transmitted Infection and Human Immunodeficiency Virus Risk Perception in a Diverse At-Risk Population of Men Who Have Sex with Men and Transgender Individuals.AIDS Patient Care STDS2021
33449236HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic.AIDS Behav2021
32895573Recommendations for measuring HIV reservoir size in cure-directed clinical trials.Nat Med2020
33239444Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.Proc Natl Acad Sci U S A2020
30399039Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research.J Acquir Immune Defic Syndr2019
31533030Mapping the Lineage Relationship between CXCR5<sup>+</sup> and CXCR5<sup>-</sup> CD4<sup>+</sup> T Cells in HIV-Infected Human Lymph Nodes.Cell Rep2019
31434737Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.J Virol2019
31566579DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.J Clin Invest2019
31082665Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.Drug Alcohol Depend2019
28744666Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants.AIDS Behav2018
29858286Identification and characterization of HIV-specific resident memory CD8<sup>+</sup> T cells in human lymphoid tissue.Sci Immunol2018
30235286Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.PLoS One2018
30445896Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial.HIV Clin Trials2018
29669853CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.Sci Transl Med2018
29667531Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?J Int Assoc Provid AIDS Care2018
29370030BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.Retina2018
29325070Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.J Infect Dis2018
27811319Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).J Infect Dis2017
  • 1 - 50 of 196

Recommended Authors

Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 2
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 4
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 6
University of California san francisco
Career Start Year 2002
Number of shared co-authors 13
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 14
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 5
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 4
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 5
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 19
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 14
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 12
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 11
Sacramento Medical Center, Kaiser Permanente Northern California
Career Start Year 1988
Number of shared co-authors 3
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 6
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 2
VA Medical Center
Career Start Year 1986
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 9
University of Washington
Career Start Year 1984
Number of shared co-authors 19
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 3
Perelman School of Medicine, the University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 5
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 8
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 11
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 7
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 5
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 4
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 11
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 4
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 11

Collaborators

Perelman School of Medicine, University of Pennsylvania
Co-authored papers 24
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 20
Co-authored papers 13
Co-authored papers 13
Co-authored papers 10
Co-authored papers 9
University of Pennsylvania School of Medicine
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
IRCCS-ISMETT
Co-authored papers 8
Wistar Institute
Co-authored papers 8
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Co-authored papers 7
MK University of Rochester
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Dornsife School of Public Health, Drexel University.
Co-authored papers 6
university of california los angeles Center for Clinical AIDS Research & Education
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
University of Pennsylvania
Co-authored papers 4
Fred Hutchinson Cancer Center
Co-authored papers 4
University of Pennsylvania Perelman School of Medicine
Co-authored papers 4
University of Pennsylvania
Co-authored papers 4
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
Institute for Immunology, University of Pennsylvania Perelman School of Medicine
Co-authored papers 4
Co-authored papers 4
University of Washington
Co-authored papers 3